Moderna, Novavax hit 52-week lows

Sep. 29, 2022 10:47 AM ETModerna, Inc. (MRNA), NVAXNVS, INO, VXRT, OCGN, VALNBy: Dulan Lokuwithana, SA News Editor84 Comments

Coronavirus and Global finance


  • The shares of COVID-19 vaccine makers witnessed a sharp decline on Thursday morning, with Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX) reaching 52-week lows.
  • Its rivals in COVID-19 vaccine development, Valneva (VALN), Vaxart (VXRT), Ocugen (

Recommended For You

Comments (84)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.